A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan,Cancer Medicine

当前位置： X-MOL 学术 › Cancer Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan
Cancer Medicine ( IF 2.9 ) Pub Date : 2023-12-11 , DOI: 10.1002/cam4.6767
Shogo Wada ₁ , Dai Ogata ₁ , Tairo Kashihara ₂ , Kae Okuma ₂ , Hirofumi Eto _{1,

3} , Eiji Nakano ₁ , Akira Takahashi _{1,

4} , Kenjiro Namikawa ₁ , Hiroshi Igaki ₂ , Naoya Yamazaki ₁

Affiliation

Melanoma brain metastasis (MBM) has a poor prognosis, although recent treatments, including immune checkpoint inhibitors and targeted therapy, have improved the prognosis. However, these systemic therapies have been reported to be less efficient for Asian patients. We investigated the survival of Asian patients with MBM and the effectiveness of systemic therapies.

中文翻译：